The company will unveil preliminary findings showing that Broncho-Vaxom was associated with a 28–38% reduction in respiratory tract infection rates at 12 months
Dr. Quirk said the program’s mechanism offers a targeted approach to disrupted brain signaling in compulsivity-related disorders
Preclinical CRO strengthens leadership team with key executive appointments as it scales its human tissue-based drug discovery platform
Dengue, a mosquito-borne viral disease, is emerging as a growing public health threat across Africa
Investigational once-weekly GLP-1 and amylin receptor agonist achieves up to 14.6% weight loss and significant blood sugar reductions
The technology enables clinicians to assess brain tissue and microvascular reperfusion directly in the angiography suite, potentially improving stroke treatment decisions and patient outcomes
BPDCN typically presents with skin lesions before rapidly spreading to the bone marrow, lymph nodes
The company is set to unveil new clinical data across obesity, diabetes, kidney, and liver disease programs
Company launches clinical study of AI-designed oral formulation following MHRA approval, marking a major milestone in AI-driven drug development.
Subscribe To Our Newsletter & Stay Updated
_256_275.jpeg)
